Split activator of CRISPR/Cas12a for direct and sensitive detection of microRNA
Analytica Chimica Acta · 2024-05 · 1303 · 342477
DOI: 10.1016/j.aca.2024.342477 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytica Chimica Acta, 2024-05. Verfasst von Wen He und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Clinical Laboratory Diagnostics (Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, Chongqing, 4…. Hauptthemen laut MEDLINE: MicroRNAs, Nucleic Acids. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Natural Science Foundation of Chongqing Municipality, Natural Science Foundation Project of Chongqing, National Natural Science Foundation of China.
Abstract (Originalsprache)
CRISPR/Cas12a-based nucleic acid assays have been increasingly used for molecular diagnostics. However, most current CRISPR/Cas12a-based RNA assays require the conversion of RNA into DNA by preamplification strategies, which increases the complexity of detection. Here, we found certain chimeric DNA-RNA hybrid single strands could activate the trans-cleavage activity of Cas12a, and then discovered the activating effect of split ssDNA and RNA when they are present simultaneously. As proof of concept, split nucleic acid-activated Cas12a (SNA-Cas12a) strategy was developed for direct detection of miR-155. By adding a short ssDNA to the proximal end of the crRNA spacer sequence, we realized the direct detection of RNA targets using Cas12a. With the assistance of ssDNA, we extended the limitation that CRISPR/Cas12a cannot be activated by RNA targets. In addition, by taking advantage of the programmability of crRNA, the length of its binding to DNA and RNA was optimized to achieve the optimal efficiency in activating Cas12a. The SNA-Cas12a method enabled sensitive miR-155 detection at pM level. This method was simple, rapid, and specific. Thus, we proposed a new Cas12a-based RNA detection strategy that expanded the application of CRISPR/Cas12a.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Clinical Laboratory Diagnostics (Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, Chongqing, 400016, PR China.
- Chongqing Key Laboratory of Sichuan-Chongqing Co-construction for Diagnosis and Treatment of Infectious Diseases Integrated Traditional Chinese and Western Medicine, Chongqing Hospital of Traditional Chinese Medicine, C…
- Key Laboratory of Clinical Laboratory Diagnostics (Ministry of Education), College of Laboratory Medicine, Chongqing Medical University, Chongqing, 400016, PR China. Electronic address: yanyurong@cqmu.edu.cn.
Förderung
- Natural Science Foundation of Chongqing Municipality
- Natural Science Foundation Project of Chongqing
- National Natural Science Foundation of China
Zitieren
APA
He, W., Li, X., Li, X., Guo, M., Zhang, M., Hu, R., Li, M., Ding, S., & Yan, Y. (2024). Split activator of CRISPR/Cas12a for direct and sensitive detection of microRNA. Analytica Chimica Acta, 1303, 342477. https://doi.org/10.1016/j.aca.2024.342477
Vancouver
He W, Li X, Li X, Guo M, Zhang M, Hu R, et al. Split activator of CRISPR/Cas12a for direct and sensitive detection of microRNA. Analytica Chimica Acta. 2024;1303:342477. doi:10.1016/j.aca.2024.342477
BibTeX
@article{He2024,
author = {He, Wen and Li, Xinyu and Li, Xinmin and Guo, Minghui and Zhang, Mengxuan and Hu, Ruiwei and Li, Menghan and Ding, Shijia and Yan, Yurong},
title = {Split activator of CRISPR/Cas12a for direct and sensitive detection of microRNA},
journal = {Analytica Chimica Acta},
year = {2024},
volume = {1303},
pages = {342477},
doi = {10.1016/j.aca.2024.342477}
}
EUVIMED